FDA Approves First On-Body Injector for Cancer Treatment

The U.S. Food and Drug Administration has approved Sanofi's Sarclisa Escena for multiple myeloma, marking a significant advancement in cancer care. This is the first anticancer treatment in the US to be administered via an on-body injector, offering patients a more convenient and potentially less burdensome way to receive their medication. The new delivery method aims to improve the patient experience for those undergoing treatment for multiple myeloma.